Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Sep 27, 2026; 18(9): 118865
Published online Sep 27, 2026. doi: 10.4240/wjgs.118865
Published online Sep 27, 2026. doi: 10.4240/wjgs.118865
Table 2 Temporal changes in bilirubin and hepatocellular enzymes, mean ± SD
| Parameter | Time | Observation group (n = 55) | Control group (n = 45) | Difference | P value |
| TBIL (μmol/L) | Baseline | 152.3 ± 35.8 | 148.7 ± 38.2 | 3.6 | 0.616 |
| 1 week | 98.5 ± 22.3 | 115.8 ± 26.5 | -17.3 | 0.001 | |
| 2 weeks | 68.3 ± 15.8 | 89.5 ± 21.2 | -21.2 | < 0.001 | |
| 4 weeks | 42.5 ± 12.3 | 68.7 ± 18.5 | -26.2 | < 0.001 | |
| ALT (U/L) | Baseline | 95.3 ± 28.5 | 92.7 ± 31.2 | 2.6 | 0.653 |
| 4 weeks | 38.5 ± 12.3 | 56.8 ± 18.5 | -18.3 | < 0.001 |
- Citation: Wang Y, Xi JW, Zhang WS, Wu QL, Liu F, Xie YL, Cao ZL. Internal vs oral bile reinfusion for hepatic recovery after percutaneous transhepatic cholangiodrainage. World J Gastrointest Surg 2026; 18(9): 118865
- URL: https://www.wjgnet.com/1948-9366/full/v18/i9/118865.htm
- DOI: https://dx.doi.org/10.4240/wjgs.118865